当前位置:首页 - 行情中心 - 晶升股份(688478) - 财务分析 - 利润表

晶升股份

(688478)

  

流通市值:37.90亿  总市值:50.71亿
流通股本:1.03亿   总股本:1.38亿

利润表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、营业总收入191,498,908.84158,390,552.5970,813,548.29424,966,295.63
  营业收入191,498,908.84158,390,552.5970,813,548.29424,966,295.63
二、营业总成本232,323,223.13189,893,017.6885,352,091.68397,410,430.05
  营业成本176,043,207.22152,257,882.8167,606,915.96314,184,752.9
  税金及附加1,171,108.95780,033.42357,895.531,357,814.68
  销售费用3,594,524.452,593,610.271,215,588.845,094,269.71
  管理费用20,747,686.7814,040,114.416,985,623.3534,168,486.64
  研发费用31,226,528.5920,563,911.999,415,848.6544,247,118.83
  财务费用-459,832.86-342,535.22-229,780.65-1,642,012.71
  其中:利息费用5,806.445,806.445,806.44129,251.87
  其中:利息收入542,856.76406,767.48272,418.371,896,301.45
三、其他经营收益
  加:公允价值变动收益-109,916.52-3,066,279.37-528,379.76-13,860,967.72
  加:投资收益17,302,240.1615,029,287.966,322,273.4342,311,393.18
  资产处置收益---2,321.25189,072.29
  资产减值损失(新)477,527.73420,878.58-46,263.93-6,031,178.84
  信用减值损失(新)-2,848,617.52-2,274,483.58-2,351,083.74-539,156.49
  其他收益9,859,623.059,702,284.056,838,505.1811,686,423.84
四、营业利润-16,143,457.39-11,690,777.45-4,305,813.4661,311,451.84
  加:营业外收入9,760-34,740-126,722.56
  减:营业外支出1,060,626.355,032.04-2,081,865.18
五、利润总额-17,194,323.74-11,730,549.49-4,305,813.4659,356,309.22
  减:所得税费用-5,933,610.41-4,279,607.53-1,772,652.75,609,210.64
六、净利润-11,260,713.33-7,450,941.96-2,533,160.7653,747,098.58
(一)按经营持续性分类
  持续经营净利润-11,260,713.33-7,450,941.96-2,533,160.7653,747,098.58
(二)按所有权归属分类
  归属于母公司股东的净利润-11,260,713.33-7,450,941.96-2,533,160.7653,747,098.58
  扣除非经常损益后的净利润-27,161,302.59-19,737,475.58-7,834,671.6530,225,845.92
七、每股收益
  (一)基本每股收益-0.08-0.05-0.020.39
  (二)稀释每股收益-0.08-0.05-0.020.39
八、其他综合收益1,951,754.91-630,210.48-1,046,582.69-1,162,815.8
  归属于母公司股东的其他综合收益1,951,754.91-630,210.48-1,046,582.69-1,162,815.8
九、综合收益总额-9,308,958.42-8,081,152.44-3,579,743.4552,584,282.78
  归属于母公司股东的综合收益总额-9,308,958.42-8,081,152.44-3,579,743.4552,584,282.78
公告日期2025-10-302025-08-302025-04-292025-04-29
审计意见(境内)标准无保留意见
TOP↑